Cargando…
Response to Zoledronic Acid in Patients with Active Paget's Disease of Bone: A Retrospective Study
BACKGROUND: Traditionally, bisphosphonates are used to treat active Paget's disease of bone (PDB). Intravenous zoledronic acid (ZA) is the most effective treatment option leading to sustained remission. OBJECTIVE: The primary objective of this study was to analyze the effect of intravenous ZA i...
Autores principales: | Durgia, Harsh, Sahoo, Jayaprakash, Kamalanathan, Sadishkumar, Palui, Rajan, Kumar, Ritesh, Halanaik, Dhanapathi, Ananthakrishnan, Ramesh, Sankar, Gowri, Sridharan, Kalyani, Raj, Henith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446674/ https://www.ncbi.nlm.nih.gov/pubmed/31016165 http://dx.doi.org/10.4103/ijem.IJEM_327_18 |
Ejemplares similares
-
Role of bisphosphonates in the management of acute Charcot foot
por: Durgia, Harsh, et al.
Publicado: (2018) -
Effect of 2 mg Versus 4 mg of Intravenous Zoledronic Acid on Bone Mineral Density at the Lumbar Spine in Indian Postmenopausal Women with Osteoporosis: A Double-blind Parallel-arm Randomized Controlled Trial
por: Durgia, Harsh, et al.
Publicado: (2021) -
SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review
por: Raj, Henith, et al.
Publicado: (2019) -
Timing of osteoporosis therapies following fracture: the current
status
por: Palui, Rajan, et al.
Publicado: (2022) -
Growth hormone and gastrointestinal malignancy: An intriguing link
por: Palui, Rajan, et al.
Publicado: (2023)